# Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis

> **NCT02605746** · EARLY_PHASE1 · COMPLETED · sponsor: **St. Joseph's Hospital and Medical Center, Phoenix** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma
- Brain Metastases

## Interventions

- **DRUG:** ceritinib 750mg

## Key facts

- **NCT ID:** NCT02605746
- **Lead sponsor:** St. Joseph's Hospital and Medical Center, Phoenix
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-17
- **Primary completion:** 2018-11-29
- **Final completion:** 2019-07-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-12-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605746, "Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02605746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*